{"id":"W4311354885","doi":"10.2147/ppa.s379065","title":"Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)","year":2022,"lang":"en","type":"article","venue":"Patient Preference and Adherence","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences North; University Health Network; Ottawa Hospital; Vancouver Infectious Diseases Centre; Centre hospitalier de l'Université Laval; University of British Columbia; Toronto General Hospital; University of Toronto; Centre Hospitalier de l’Université de Montréal; University of Regina; McGill University; McGill University Health Centre; Canadian Institutes of Health Research","funders":"Canadian Institutes of Health Research; ViiV Healthcare","keywords":"Dolutegravir; Medicine; Lamivudine; Abacavir; Randomized controlled trial; Internal medicine; Randomization; Zidovudine; Tenofovir alafenamide; Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy; Virology; Viral disease; Virus","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002473539,0.0011354,0.002116619,0.0004603094,0.0005297599,0.0009580468,0.0006597715,0.001681594,0.002997256],"category_scores_gemma":[0.002029755,0.0007184374,0.001992088,0.0004129886,0.0008641367,0.0007182871,0.0004292126,0.002316671,0.0004035546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009428001,"about_ca_system_score_gemma":0.001700773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00293667,"about_ca_topic_score_gemma":0.004522069,"domain_scores_codex":[0.9989869,0.0005239205,0.00007758763,0.0001283962,0.0000870438,0.0001960693],"domain_scores_gemma":[0.9980984,0.0004389712,0.0004370812,0.0001312652,0.0001443856,0.0007498548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9358329,0.0393688,0.004598186,0.0003868407,0.0006037724,0.00003343548,0.0001447218,0.0002482584,0.00200014,0.00002363197,0.0002681652,0.01649108],"study_design_scores_gemma":[0.6292119,0.3561685,0.01303693,0.00004309051,0.0004523519,0.000029699,0.00005175484,0.0003236276,0.0004413745,0.00003838742,0.0001848284,0.00001755593],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978047,0.0004683922,0.00007570769,0.00007006505,0.00004353194,0.001065309,0.000189936,0.00001466958,0.0002677838],"genre_scores_gemma":[0.9957795,0.0005529552,0.0005644041,0.0002608518,0.0001395358,0.001728978,0.0003392933,0.000005324356,0.0006291677],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002997256,"threshold_uncertainty_score":0.01308143,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04360992984571242,"score_gpt":0.3438223160218185,"score_spread":0.3002123861761061,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}